Home > Journals > Gazzetta Medica Italiana Archivio per le Scienze Mediche > Past Issues > Gazzetta Medica Italiana Archivio per le Scienze Mediche 2003 October;162(5) > Gazzetta Medica Italiana Archivio per le Scienze Mediche 2003 October;162(5):117-20

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Share

 

ORIGINAL ARTICLES   

Gazzetta Medica Italiana Archivio per le Scienze Mediche 2003 October;162(5):117-20

Copyright © 2003 EDIZIONI MINERVA MEDICA

language: Italian

Local administration of soy isoflavones in postmenopausal vulvovaginal disease

Morgante G., La Marca A., Lanzetta D., Musacchio M. C., De Leo V.

Dipartimento di Pediatria, Ostetricia e Medicina della Riproduzione, Clinica Ostetrica e Ginecologica, Università degli Studi di Siena, Siena


PDF


Aim. Hor­mo­nal replace­ment ther­a­py (HRT) is ­safe and effec­tive in the ­relief of post­men­o­pau­sal symp­toms. For the gen­i­tal ­tract (vag­i­nal dry­ness and thin­ning of gen­i­tal tis­sue) a ­local estro­gen ther­a­py can be ­used. If the ­patient pre­fers to ­avoid hor­mones, ­there are ­some prep­ar­a­tions ­with soy iso­fla­vones ­extracts ­that local­ly ­applied ­induce ­relief of uro­gen­i­tal symp­tom­a­tol­o­gy ­caused by estro­gen ­loss.
Meth­ods. Thir­ty ­healthy men­o­pau­sal wom­en (>1 ­year) ­with uro­gen­i­tal dis­eas­es ­were examined, ran­dom­ly divid­ed ­into 2 ­groups and treat­ed for 3 ­months: ­group A, 18 wom­en treat­ed ­with soy iso­fla­vones ­cream (1 vag­i­nal appli­ca­tion dai­ly); ­group B, 12 wom­en treat­ed ­with a mois­ture gel. ­Local symp­tom­a­tol­o­gy was eval­u­at­ed: dry­ness, dys­pa­reu­nia e ­itch-burn­ing.
­Results. ­Both ­groups ­showed improve­ment in symp­tom­a­tol­o­gy. In ­group A ­there was a sig­nif­i­cant reduc­tion (p<0.005) com­pared to ­group B at the 1st and 3rd ­month of ther­a­py for dys­pa­reu­nia and ­itch-burn­ing. Dry­ness ­showed the ­same reduc­tion in ­both ­groups.
Con­clu­sion. The pos­sibil­ity to use a prep­ar­a­tion ­like ­that ­used in the ­present ­study ­with an ade­quate ­dose of soy iso­fla­vones ­makes it pos­sible not ­only to ­treat, ­with a con­tin­ued use, vul­vo-vag­i­nal symp­tom­a­tol­o­gy but to pre­vent its appear­ance.

top of page